KAI
LIVE

Serial Number

79408927

Owner

KAI Conversations Limited

Attorney

Richard S. Finkelstein

Filing Date

Apr 5, 2024

Add to watchlist:

No watchlists yet
View on USPTO

KAI Trademark

Serial Number: 79408927 • Registration: 8190697

KAI is a trademark filed by KAI Conversations Limited on April 5, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

KAI Conversations Limited (3 trademarks)

1 The Byre, Frogmill Court

Entity Type: 99

Trademark Details

Filing Date

April 5, 2024

Registration Date

March 31, 2026

Published for Opposition

February 10, 2026

Goods & Services

Artificial intelligence technology consultancy in the healthcare and pharma fields; computer programming services for the analysis of data for managing customer interactions and providing automated customer support in healthcare industry by providing data on the acoustic, textual, and facial emotion aspects of conversations between healthcare or pharma professionals and patients; computer programming in the healthcare and pharma fields; data conversion of electronic information in the healthcare and pharma fields; data mining in the healthcare and pharma fields; design and development of computer software for evaluation and calculation of data in the healthcare and pharma fields; platform as a service featuring software for the analysis of data in healthcare industry, namely analysis of non-verbal communication and patient satisfaction; platform as a service featuring software for the analysis of data in healthcare industry, namely analysis of acoustic, textual, and facial emotion aspects of conversations between healthcare or pharmaceutical professionals and patients; platforms for artificial intelligence as software as a service featuring software for the analysis of data in healthcare industry, namely analysis of non-verbal communication and patient satisfaction; platforms for artificial intelligence as software as a service featuring software for the analysis of data in healthcare industry, namely analysis of acoustic, textual, and facial emotion aspects of conversations between healthcare or pharmaceutical professionals and patients; technology research in the field of artificial intelligence for healthcare and pharmaceutical applications; research in the field of artificial intelligence technology for use in healthcare and pharmaceutical fields; software as a service featuring computer software platforms for analysis of data in healthcare industry using artificial intelligence; software as a service featuring software for machine learning in the healthcare and pharmaceutical industries; software as a service featuring machine learning software for deep learning and deep neural computer networks in healthcare and pharmaceutical industries; software as a service featuring software for the analysis of data in healthcare industry; software development in the framework of software publishing in healthcare and pharmaceutical industries; providing online non-downloadable cloud computing software for the analysis of data in healthcare industry; all of the foregoing being limited to life sciences, pharmaceutical and healthcare fields; none of the above related to deploying conversational AI or chatbot functions, monitoring casino activities, fraud prevention or detection, advertising, banking, or completing and processing global trade and supply chain transactions

Downloadable AI software for the analysis of data in healthcare industry; VR goggles; downloadable artificial intelligence software for the analysis of data in healthcare industry; data processing apparatus with artificial intelligence for the analysis of data for managing customer interactions and providing automated customer support in healthcare industry by providing data on the acoustic, textual, and facial emotion aspects of conversations between healthcare or pharma professionals and patients; downloadable artificial intelligence software for surveillance of persons for healthcare and pharmaceutical purposes; downloadable artificial intelligence software for data analysis, namely analysis of non-verbal communication and patient satisfaction; downloadable artificial intelligence software for data analysis, namely analysis of acoustic, textual, and facial emotion aspects of conversations between healthcare or pharma professionals and patients; downloadable artificial intelligence software for healthcare, namely, software for recording vital signs and non-verbal communication; downloadable artificial intelligence and machine learning software for the analysis of data in healthcare industry; downloadable interactive software based on artificial intelligence for the analysis of data in healthcare industry, namely analysis of non-verbal communication and patient satisfaction; downloadable computer application software for use with wearable computer devices, namely, for recording health information; downloadable mobile applications for use with wearable computer devices, namely, for recording health information; downloadable machine learning software; downloadable machine learning software for healthcare, namely for analysis of non-verbal communication and patient satisfaction; all of the foregoing being limited to life sciences, pharmaceutical and healthcare applications; none of the above related to deploying conversational AI or chatbot functions, monitoring casino activities, fraud prevention or detection, advertising, banking, or completing and processing global trade and supply chain transactions

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 23, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 6, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 6, 2026 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 31, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 31, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 10, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 10, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 4, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 16, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 16, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 16, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 16, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 16, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 22, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 22, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 22, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 22, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jun 22, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jun 22, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 12, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 12, 2025 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 30, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 30, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 30, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 30, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 30, 2025 COAR
REFUSAL PROCESSED BY IB
Dec 7, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 16, 2024 RFCS
REFUSAL PROCESSED BY MPU
Nov 16, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 12, 2024 RFCR
NON-FINAL ACTION WRITTEN
Nov 11, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 9, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 8, 2024 MAFR
APPLICATION FILING RECEIPT MAILED
Nov 8, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 8, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 7, 2024 REPR